FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094375 [Registered on: 08/09/2025] Trial Registered Prospectively
Last Modified On: 04/09/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Randomized controlled clinical trial to study the efficacy of the Shivlingi Beeja (Bryonia Laciniosa) churna in the manegement of PCOS 
Scientific Title of Study   Randomized controlled clinical trial to study the efficacy of the Shivlingi Beeja (Bryonia laciniosa) churna in the manegement of PCOS 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  VD PRASHANT DALVI 
Designation  PhD scholerscholar  
Affiliation  Associate Professor, R A Podar Medical College AYU,  
Address  Departmnet of Prasutitantra and Streeroga, Dr D. Y. Patil College of Ayurved and Research centre, Pimpari, Pune, 411018
R A Podar Medical College AYU, Annebezant road, Worli,Mumbai
Mumbai
MAHARASHTRA
411018
India 
Phone  9822783636  
Fax    
Email  drdalvipn@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  VD PRASHANT DALVI 
Designation  PhD Scholar 
Affiliation  Associate Professor, R. A. Podar Medical College AYU, 
Address  Departmnet of Prasutitantra and Streeroga, Dr D. Y. Patil College of Ayurved and Research centre, Pimpari, Pune, 411018
R A Podar Medical College AYU, Annebezant road, Worli, Mumbai
Mumbai
MAHARASHTRA
411018
India 
Phone  9822783636  
Fax    
Email  drdalvipn@gmail.com  
 
Details of Contact Person
Public Query
 
Name  VD PRASHANT DALVI 
Designation  PhD Scholar 
Affiliation  Associate Professor, R A Podar Medical College AYU, Worli, Mumbai 
Address  Dr D. Y. Patil College of Ayurved and Research centre, Pimpari, Pune, 411018
R A Podar Medical College AYU, Annebezant road, Worli, Mumbai
Mumbai
MAHARASHTRA
411018
India 
Phone  9822783636  
Fax    
Email  drdalvipn@gmail.com  
 
Source of Monetary or Material Support  
Dr D. Y. Patil College of Ayurved Hospital, Pimpari, Pune 411018 
 
Primary Sponsor  
Name  Dr D Y Patil College of Ayurved Hospital Pimpari Pune  
Address  Pimpari Pune 411028 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prashant Dalvi  Dr D Y Patil Ayurved Hospital  OPd and IPD, Department of Prasutitantra and Streeroga,Dr D Y Patil Ayurved Hospital,Pimpari, Pune 411018
Pune
MAHARASHTRA 
9822783636

drdalvipn@gmail.com 
Dr Prashant Dalvi  R. A. Podar Medical College and Hospital  Annebezant road, Worli, Mumbai
Mumbai
MAHARASHTRA 
9822783636

drdalvipn@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Dr. D. Y. Patil College of Ayurved And reasearch centre, Pimpari Pune  Approved 
IEC R A Podar Medical College AYU   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O||Medical and Surgical. Ayurveda Condition: ARTAVADOSHAH/ARTAVADUSHTIH/RAJODOSHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Tab. Metformin500 mg OD Pragbhakta/ before meals 3 months Oral Monthly
2Intervention ArmDrugClassical(1) Medicine Name: Shivlingi beeja churna, Reference: 10. Deepak Acharya, Shivlingi: A Common but Important Twine in Patalkot. Ame Chronicle, Dec 18: 2006, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 90 Days, anupAna/sahapAna: Yes(details: -koshna jal), Additional Information: -
 
Inclusion Criteria  
Age From  19.00 Year(s)
Age To  35.00 Year(s)
Gender  Female 
Details  Married Unmarried Both.
PCOS diagnosed by Rotterdam crieteria 2/3 
 
ExclusionCriteria 
Details  Patients showing signs and symptoms other than PCOS
Patients having any other disease causing Oligomenorrhea and Anovulation excluding PCOS on above criteria i.e. Hypogonadotrophic Hypogonadism, Premature Ovarian Failure.
4. Patients suffering from a) Congenital Adrenal Hyperplasia b) Severe Insulin resistance (Insulin dependent Diabetes Mellitus) c) Androgen secreting Ovarian and Adrenal tumors d) Thyroid abnormalities e) Cushing’s syndrome f) Cardiac disease g) Hyperprolactemia.
Patients with any organic lesions of Reproductive Tract like TB, Ca, Congenital anomalies, any other pelvic pathologies.
A current or previous (within 3 months) use of OC Pills, Glucocorticoids, Antiandrogens, Antidiabetics, Antiobesity drugs or any Hormonal Therapy. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Regularisation of menstrual cycle  Regularisation of menstrual cycle after 90 days 
 
Secondary Outcome  
Outcome  TimePoints 
effect of Shivlingi beeja churna on Insulin resistance  Sr Inshulin levels 
Change in BMI  BMI calculated 
 
Target Sample Size   Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  15/09/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

“RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF THE SHIVLINGI BEEJA (BRYONIA LACINIOSA ) CHURNA  IN THE MANEGEMENT OF PCOS.”

Introduction:

PCOS is one of the most common reproductive endocrinological disorder with a broad spectrum of clinical manifestations affecting 8 to 10%1.2 in reproductive age group. In PCOS ovaries fail to develops a mature egg and generate only multiple immature follicles with increase in ovarian size represented by oligomenorrhoea or amenorrhea, hyperandrogenism (Clinical Or Biochemical) and polycystic ovaries in USG which is diagnosed by Rotterdam Criteria (2003)3. The pathogenesis of PCOS is still largely unknown and until now medical care of these subjects has been limited to symptomatic control of cosmetic concerns, menstrual dysfunctions and infertility. Women with the syndrome are frequently insulin resistant, independent of obesity14. In these regards, much of the data supports that insulin resistance and the associated hyperinsulinemia plays an important role in PCOS. Insulin has direct effect on ovarian steroidogenesis stimulating androgen synthesis in theca cells leading to the syndrome7,15.

In Ayurvedic classics, PCOS maybe consider under various headings as Artavakshaya, Anartava, Nashtartava, Granthibhoota Artavdushti, Vandhyatva Yonivyapada, and Santarpanottha strotodushti. Pushpaghni Jataharini described in Kashyapa Samhita Khilsthana is the entity which is found more resembling with symptoms of PCOS amongst the others5.

Pushpaghni represents with typical features that includes destruction of Pushpa with regular menstruation, appearance of facial hair and obesity9.

PCOS can be considered as a condition manifested due to Mithyachara, Pradushtartava Beeja Dosha4.It may be term as Vata Kaphaja artva dushti. It is a Santarpanottha vikara with Sanga, Avarana and Siragranthi form of pathogenesis. As the pathogenic factors involved in PCOS are Vata and Kapha Doshas Rasa and Meda – Dushyas, Artavavaha Strotas, Jatharagni and Dhatvagnimandya and will need Vatakaphaghna and Rasayan Chikitsa as one of the way for sampraptibhanga.

Currently the standard care treatment for women with PCOS ranges from lifestyle modifications to pharmacological interventions including Anti androgens (Spironolactone, Flutamide), Insulin lowering agents (Metformin, Thiazolidine)8 and Oral Contraceptives as a single or combined17. Though effective, they do not abolish the basic problem and treatment is also associated with various adverse effects such as irregular menstruation, gastrointestinal disturbances, weight gain.

Considering all above points from various research papers found that “Shivlingi beeja” working on male as well as female infertility. Scientific research need was expressed by various authors in their review articles. As per data present role of Shivlingi beeja was studied on male rats, which shows good results. Every paper says it works on females also but such research is not done. As per tribes of Pakalkot these seeds are to be use in females those wants to concive.10 So it has been decided to work on Shivlingi beeja. According to Ayurvedic texts Shivlingi beeja has properties like uterine tonic, Rasayana, anti-obesity and antidiabetic properties. So with the hypothesis on the basis of available literature, Herbal or Herbomineral medicines according to Ayurveda can have great benefit in PCOS to abolish basic problem without or minimal adverse effect of conventional drugs. So it is decided to study the effect of the Shivlingi beeja (bryonia laciniosa ) churna  in  PCOS.

 

 

Purpose of the study:

Purpose of present study is to Study the efficacy of Shivlingi beeja churna vati in patients with PCOS.

 

Expected duration of study and expected number of participants:

140 participants and each participant will be studied for 3 months.

Sr.No.

 

Group A

Group B

1.

Drug

Shivlingi beeja churna

Tab. Metformin

2.

Dose

3 gms OD

Luke warm water

500 mg OD

3.

Kala

Pragbhakta

Pragbhakta

4.

Duration of therapy

3 months

3 months

5.

Route of Administration

Oral

Oral

6.

Follow up

Monthly

Monthly


Criteria of Assessment:

Assessment will be done based on following criteria before and after the treatment.

 

Subjective criteria:

 

Menstrual cycle:

 

Interval between 2 cycles.

 

Hirsutism19,20,21:

 

Modified Ferrimen and Galley Visual Scoring System*

Objective 

Sr.Insulin(F)7,14,15

BSL(F)14

Insulin  Resistance

Sr.Testesterone7,14,15

PCOS Pattern and Ovarian Volume

BMI (kg/m2 )18


Observational criteria:

1: Grading for interval between two menstrual cycles 2: Assessment of Hirsutism with Modified Ferriman and Galley Visual Scoring System193: Assessment of variable BMI(Kg/m2)18  4: For Variable Sr. Insulin(F) 5: For variable Sr. Testesterone 6: For Variable BSL(F) 7: For Variable Ovarian Volume 8: For PCOS Pattern (Present or Absent)


 
Close